Filing Flows › Genworth Financial (GNW) › Guidance & outlook

Genworth Financial (GNW) guidance and outlook

Genworth Financial's 10-Q filed Nov 5, 2026 makes 51 forward-looking statements.

Guidance and outlook

Forward-looking statements, 10-Q filed Nov 5, 2026

• (“AXA”) and Santander Cards UK Limited (“Santander”) litigation, and Genworth’s planned use of proceeds from any potential recovery in connection with the litigation, including share repurchases, debt repurchases and investments in new businesses; f uture financial condition and liquidity of our businesses; and statements we make regarding the outlook of the U.S. economy.
• • inaccuracies or changes in estimates, assumptions, methodologies, valuations, projections and/or models, which result in inadequate reserves or other adverse results (including as a result of any changes in connection with quarterly, annual or other reviews, including reviews we expect to complete in the fourth quarter of 2026);
• Based on our approximate 81% ownership, we expect to receive capital returns from Enact Holdings of approximately $485 million for the full year 2026.
• We expect capital returns from Enact will continue to benefit our shareholders by funding our strategic initiatives, including new CareScout products and services, as well as share repurchases and opportunistic debt reduction.
• As we further integrate senior living communities, we are building a more comprehensive network that can support individuals across different stages of the aging journey and we expect will complement our existing home care model with a more diversified and scalable revenue stream.
• to expand and brand awareness grows, we anticipate increased traction across the platform, including greater utilization by Genworth policyholders, helping to stretch their benefit dollars further while generating claims savings in the Closed Block over time.
• We expect to invest approximately $55 million in CareScout Services for the full year 2026 to further scale the business.
• We do not anticipate any additional capital investment in CareScout Insurance in 2026 following the $85 million investment made in 2025 to enable the launch of the business.
• While it will take time to scale these businesses, we believe our investments in CareScout will drive sustainable future growth for Genworth and are aligned with our overarching priority to maximize long-term value for our shareholders.
• We will continue to take a disciplined approach in our capital allocation strategy, balancing investments in CareScout growth initiatives with returning value to shareholders and opportunistically retiring debt.
• As we manage our legacy insurance subsidiaries on a standalone basis, these entities will continue to rely on their statutory capital, significant reserves, prudent management of the in-force blocks and other management actions, including our long-term care insurance in-force rate actions, to satisfy policyholder obligations.
• We estimate that the cumulative economic benefit of approved rate increases and benefit reductions in our long-term care insurance multi-year in-force rate action plan from 2012 through the third quarter of 2026 was approximately $35.0 billion , on a net present value basis.

Genworth Financial's latest quarter

Questions

What does Genworth Financial expect?

(“AXA”) and Santander Cards UK Limited (“Santander”) litigation, and Genworth’s planned use of proceeds from any potential recovery in connection with the litigation, including share repurchases, debt repurchases and investments in new businesses; f uture financial condition and liquidity of our businesses; and statements we make regarding the outlook of the U.S. economy. • inaccuracies or changes in estimates, assumptions, methodologies, valuations, projections and/or models, which result in inadequate reserves or other adverse results (including as a result of any changes in connection with

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.